Distribution of invasive meningococcal disease cases by serogroups and age group, France and Paris area, 2001–2018. by Alexiane Baloche (12647126)

Evolution of number of cases per clade. by Eveline M. Bunge (4108897)

Subjects:

Proportional comparison of day-cases based episodes reviewed over the phone during the study period compared to 2019. by Saman Hewamana (11450155)

Subjects:

Data Sheet 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.pdf by Nourhen Agrebi (14151222)

“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”

Monthly distribution of HFMD cases in mainland China, 2011–2018. by Yuanzhe Wu (13281638)

Subjects:

Baseline characteristics of meningitis in rural Gambia: 10 years of population-based surveillance. by Usman N. Ikumapayi (13229382)

Subjects:

Schematic presentation of sampling techniques and proportional allocation of cases at public hospitals, Sidama region. by Gossa Fetene (11881537)

Subjects:

Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines. by Nazima Nasrullah (6874496)

“…<p>Concentration of RebA and Steviol showed increased significantly, whereas stevioside showed significant decrease in all the transgenic lines.…”

Results of logistic regression analysis: The younger group (<50 years old; 198 cases and 783 controls). by Mei Yang (51996)

Subjects:

Effect of intervention on neonatal mortality, case fatality of severe illness and care-seeking for severe illness. by Tanvir M. Huda (5215886)

Subjects:

Annual incidence and number of cases of HFMD in mainland China,2011–2018. by Yuanzhe Wu (13281638)

Subjects:

Two cases already known to cause COD. by Youji Asama (11938816)

Quality assessment for case-control studies. by Ya Hu (314378)

Comparison of airway parameters between case group (N = 17) and control (N = 17) group before and after treatment. by Hussein Aljawad (11873466)

Base-case results. by Ping Chen (89712)

The base case analysis. by Wenwang Lang (20293527)

“…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …”

Expression of <i>TBC1D21</i> was decreased in teratozoospermia cases. by Ya-Yun Wang (175049)

Base-case results. by Shuo Kang (1306860)

“…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …”

Base-case results. by Mingxi Xie (19812594)

“…Clinical findings have showed that deprescribing service significantly decreased inappropriate PPIs utilization. …”

The percentage of significant partial correlations (with sign matching interaction in either direction), as recovered from the base case model. by Susanne Pinto (13767952)